T1	Disorder 10 15	Tumor
N1 	Reference T1 UMLS:C0027651	Tumor
T3	Disorder 116 160	conjunctiva-cornea intraepithelial neoplasia
T4	Disorder 230 235	tumor
N2 	Reference T4 UMLS:C0027651	tumor
T6	Disorder 303 347	conjunctiva-cornea intraepithelial neoplasia
T7	Disorder 349 352	CIN
N3 	Reference T7 UMLS:C0206708	CIN
N4 	Reference T7 UMLS:C1333159	CIN
T8	Disorder 599 623	ocular surface neoplasia
N5 	Reference T8 UMLS:C0015414	ocular surface neoplasia
N6 	Reference T8 UMLS:C0015414	ocular surface neoplasia
N7 	Reference T8 UMLS:C0015414	ocular surface neoplasia
T9	Disorder 664 667	CIN
N8 	Reference T9 UMLS:C0206708	CIN
N9 	Reference T9 UMLS:C1333159	CIN
T10	Pharmacological_substance 745 761	INF alpha 2-beta
T12	Disorder 809 814	tumor
N10 	Reference T12 UMLS:C0027651	tumor
T14	Pharmacological_substance 1151 1167	INF alpha 2-beta
T16	Disorder 1207 1210	CIN
N11 	Reference T16 UMLS:C0206708	CIN
N12 	Reference T16 UMLS:C1333159	CIN
T17	Disorder 1261 1285	increase of tumor volume
N13 	Reference T17 UMLS:C0027651	increase of tumor volume
T18	Pharmacological_substance 260 289	interferon (INF) alpha 2-beta
T19	Pharmacological_substance 79 102	interferon alpha 2-beta
T5	Subject 359 366	patient
T11	Subject 467 482	81-year-old man
T13	Pharmacological_substance 542 555	anticoagulant
N1000 	Reference T13 MeSH:D000925	anticoagulant
T22	Disorder 1048 1051	CIN
N14 	Reference T22 UMLS:C0206708	CIN
N15 	Reference T22 UMLS:C1333159	CIN
T23	Subject 106 112	a case
T24	Disorder 501 537	neoplasies of the colon and prostate
